Regulatory interactions between lipids and carbohydrates: The glucose fatty acid cycle after 35 years

Diabetes/Metabolism Reviews

Volumn 14, Issue 4, 1998, Pages 263-283

  Randle, Philip J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; FATTY ACID; GLUCOSE; GLYCOGEN; LIPID;

CELL RESPIRATION; ENZYME ACTIVITY; ENZYME MECHANISM; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE UTILIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LIPID STORAGE; LIVER METABOLISM; METABOLIC REGULATION; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW;

ANIMALS; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; GLUCOSE; HUMANS; INSULIN; ISLETS OF LANGERHANS; LIVER GLYCOGEN; OXIDATION-REDUCTION; PYRUVATE DEHYDROGENASE COMPLEX;

ANIMALIA;

EID: 0032452225     PISSN: 07424221     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0895(199812)14:4<263::AID-DMR233>3.0.CO;2-C     Document Type: Review

References (174)

1. Randle PJ, Kerbey AL, and Espinal J: Mechanisms decreasing glucose oxidation in diabetes and starvation: role of lipid fuels and hormones. Diabetes/Metabolism Reviews 4: 623-628, 1988.
2. Benedict FG: A Study of Prolonged Fasting. Carnegie Institute of Washington, Publication 203.
3. Benedict FG, and Joslin EP: Metabolism in Diabetes Mellitus. Carnegie Institute of Washington, Publication 136, 1910, pp. 3-234.
4. Cahill GF Jr, and Owen OE: Some observations on carbohydrate metabolism in man. In Carbohydrate Metabolism and its Disorders, Dickens F, Randle PJ, and Whelan WJ, Eds. Academic Press, London, 1968, pp. 497-522.
5. Krebs HA: Metabolism of amino acids. III. Deamination of amino acids. Biochem J 29: 1620-1644, 1935.
6. Waters ET, Fletcher JP, and Mirsky IA: Relation between carbohydrate and 3-hydroxybutyrate utilization by heart lung preparations. Am J Physiol 122: 542-546, 1938.
7. Drury DR, and Wick AN: Can other fuels substitute for glucose in tissues subjected to intense insulin activity. Ciba Found Colloquia Endocr 8: 211-217, 1953.
8. Dole VP. Relation between non-esterified fatty acids in plasma and metabolism of glucose. J Clin Invest 35: 150-159, 1956.
9. Williamson JR, and Krebs HA: Acetoacetate as fuel of respiration in perfused rat heart. Biochem J 80: 540-547, 1961.
10. Shipp JC, Opie LH, and Challoner DR: Fatty acids and glucose metabolism in perfused rat heart. Nature (Lond) 199: 1018-1019, 1961.
11. Newsholme EA, Manchester KL, and Randle PJ: Inhibition of phosphofructokinase reaction in perfused rat heart by respiration of ketone bodies, fatty acids and pyruvate. Nature (Lond) 193: 270-271, 1962.
12. Garland PB, Newsholme EA, and Randle PJ: Effect of fatty acids, ketone bodies, diabetes and starvation on pyruvate metabolism in rat heart and diaphragm muscle. Nature (Lond) 195: 381-383, 1962.
13. Randle PJ, Newsholme EA, and Garland PB: Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and diabetes and starvation on uptake and metabolic fate of glucose in rat heart and diaphragm muscles. Biochem J 93: 652-665, 1964.
14. Randle PJ, Garland PB, Hales CN, and Newsholme EA: The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i: 785-789, 1963.
15. Randle PJ, Garland PB, Hales CN, Newsholme EA, Denton RM, and Pogson CI: Interactions of metabolism and the physiological role of insulin. Recent Progr Horm Res 22: 1-44, 1966.
16. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, and Shulman GI: Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97: 2859-2865, 1996.
17. Randle PJ, England PJ, and Denton RM: Control of the tricarboxylate cycle and its interactions with glycolysis during acetate utilization in rat heart. Biochem J 117: 677-695, 1970.
18. Park CR, Morgan HE, Henderson MJ, Regen DM, Cadenas E, and Post RL: The regulation of glucose uptake in muscle as studied in the perfused rat heart. Recent Progr Horm Res 17: 493-529, 1961.
19. Passonneau JV, and Lowry OH: Phosphofructokinase and the Pasteur effect. Biochem Biophys Res Commun 12: 268-271, 1962.
20. Schonfield G, and Kipnis DM: Effects of fatty acids on carbohydrate and fatty acid metabolism of rat diaphragm. Am J Physiol 215: 513-522, 1968.
21. Beatty CH, and Bocek RM: Interrelationship of of carbohydrate and palmitate metabolism in skeletal muscle. Am J Physiol 220: 1928-1934, 1971.
22. Jefferson LSJ, Kochler JG, and Morgan HE: Effect of insulin on protein synthesis in skeletal muscle of isolated perfused preparation of rat hemicorpus. Proc Natl Acad Sci USA 69: 816-820, 1972.
23. Goodman MN, Berger M, and Ruderman N: Glucose metabolism in rat skeletal muscle at rest. Diabetes 23: 881-888, 1974.
24. Reimer F, Löffler J, Hennig G, and Wieland OH: The influence of insulin on glucose and fatty acid metabolism in the isolated perfused hindquarter. Hoppe Seylers Z Physiol Chem 356: 1055-1066, 1975.
25. Cuendet GS, Loten EG, and Renold AE: Evidence that the glucose fatty acid cycle is operative in isolated skeletal (soleus) muscle. Diabetologia 12: 336, 1975.
26. Rennie MJ, and Holloszy JO: Inhibition of glucose uptake and glycogenolysis by availability of oleate in well oxygenated perfused skeletal muscle. Biochem J 168: 161-170, 1977.
27. Maizels EZ, Ruderman NB, Goodman MN, and Lau D: Effect of acetoacetate on glucose metabolism in the soleus and extensor digitorum longus muscles of the rat. Biochem J 162: 234-241, 1977.
28. Hue L, Maisin L, and Rider MH: Palmitate inhibits liver glycolysis: involvement of fructose 2,6-bisphosphate in the glucose/fatty acid cycle. Biochem J 251: 541-545, 1988.
29. Berry MN, Phillips JW, Henly DC, and Clark DG: Effects of fatty acid oxidation on glucose utilization by isolated hepatocytes. FEBS Lett 119: 26-30, 1993.
30. Jacot E, DeFronzo RA, Jequier E, Maeder E, and Felber, J-P: The effect of hyperglycaemia, hyperinsulinaemia, and route of glucose administration on glucose oxidation and glucose storage Metabolism 31: 922-930, 1982.
31. Kelley DE, Mokan M, Simoneau JA, and Mandarino LJ: Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92: 91-98, 1993.
32. Thiebaud D, Jacot E, DeFronzo RA, Maeder E, Jequier E, and Felber, J-P: The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes 31: 957-966, 1982.
33. Felber JP, and Vanotti A: Effects of fat infusions on glucose tolerance and insulin plasma levels. Med Exp 10: 153-156, 1964.
34. Schalch DS, and Kipnis DM: Abnormalities in carbohydrate tolerance associated with elevated plasma nonesterified fatty acids J Clin Invest 44: 2010-2020, 1964.
35. Vouillamoz D, Temier E, Jequier E, and Felber JP: Importance of substrate competition in the mechanism of insulin resistance in man. Metabolism 36: 715-720, 1987.
36. Balasse EO, and Neef MA: Operation of the "glucose fatty acid cycle" during experimental elevations of plasma free fatty acid levels in man Eur J Clin Invest 4: 247-252, 1974.
37. Thiebaud D, DeFronzo RA, Jacot E, Golay A, Acheson K, Maeder E, Jequier H, and Felber J-P: Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism 31: 1128-1136, 1982,
38. Ferrannini E, Barrett EJ, Bevilacqua A, and DeFronzo RA: Effect of fatty acids on glucose production and utilization in man J Clin Invest 72: 1737-1747, 1983.
39. Lee KU, Lee HK, Koh CS, and Min HK: Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man. Diabetologia 31: 285-290, 1988.
40. Wolfe BM, Kllein S, Peters EJ, Schmidt BF, and Wolfe RR: Effect of elevated free fatty acids on glucose oxidation in normal humans. Metabolism 37: 323-329, 1988.
41. Baron AD, Brechtel G, and Edelman SV: Effects of free fatty acids and ketone bodies on in vivo non insulin-mediated glucose utilization and production in humans. Metabolism 38: 1056-1061, 1989.
42. Bonadonna RC, Zych K, Boni C, Ferrannini E, and DeFronzo RA: Time dependence of the interaction between lipid and glucose in humans. Am J Physiol 257: E49-E56, 1989.
43. Felley CP, Felley EM, Vanmelle GD, Frascarolo P, Jequier E, and Felber JP: Impairment of glucose disposal by infusion of triglycerides in humans: role of glycemia. Am J Physiol 256: E747-E752, 1989.
44. Chambrier CC, Picard S, Vidal H, Cohen R, Riou JP, and Beylot M: Interactions of glucagon and free fatty acids with insulin in control of glucose metabolism. Metabolism 39: 976-984, 1990.
45. Walker M, Fulcher GR, Catalano C, Petranyi G, Orskov H, and Alberti KGMM: Physiological levels of plasma non-esterified fatty acids impair forearm glucose uptake in normal man Clin Sci 79: 167-174, 1990.
46. Boden G, Jadell F, White J, Liang Y, Mozzoli M, Chen X, Coleman E, and Smith C: Effect of fat on insulin-stimulated carbohydrate metabolism in normal man. J Clin Invest 88: 960-966, 1991.
47. Yki-Jarvinen H, Puhakeinen I, and Koivisto VA: Effect of free fatty acids on glucose uptake and non-oxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation. J Clin Endocrinol Metab 72: 1266-1277, 1991.
48. Boden G, and Jadell F: Effects of lipid on basal carbohydrate metabolism in normal men. Diabetes 40: 686-692, 1991.
49. Piatti PM, Monti LD, Pacchioni M, Pontiroli AE, and Pozza G: Forearm insulin-mediated and non-insulin-mediated glucose uptake and muscle metabolism in man: role of free fatty acids and blood glucose levels. Metabolism 40: 926-933, 1991.
50. Johnson AB, Argyraki M, Thow JC, Cooper BG, Fulcher G, and Taylor R: Effect of increased free fatty acid supply on glucose metabolism and skeletal muscle glycogen synthase activity in normal man. Clin Sci 82: 219-226, 1992.
51. Boden G, Chen X, Ruiz J, White JV, and Rossetti L: Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93: 2438-2446, 1994.
52. Boden G, Chen X, Rosner J, and Barton M: Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44: 1239-1242, 1995.
53. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46: 3-10, 1997.
54. Nuutila P, Koivisto VA, Knuuti J, Ruotsalainen U, Teras M, Haaparanta M, Bergman J, Solin O, Voipiopulkki LM, Wegelius U, and Yki-Jarvinen H: Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo J Clin Invest 89: 1767-1774, 1992.
55. Meyer C, Nadkarni V, Stumvoll M, and Gerich J: Human kidney free fatty acid and glucose uptake: evidence for a renal glucose fatty acid cycle. Am J Physiol 36: E650-E654, 1997.
56. Fanelli C, Calderone S, Epifano L, Devincenzo A, Modarelli F, Pampanelli S, Perriello G, Defeo P, Brunetti P, Gerich JE, and Bolli GB: Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest 92: 1617-1622, 1993.
57. Nuutila P, Knuuti MJ, Raitakari M, Ruotsalainen U, Teras M, Voipiopulkki LM, Haaparanta M, Solin O, Wegelius U, and Yki-Jarvinen H: Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans. Am J Physiol 30: E941-E946, 1994.
58. Knuuti MJ, Maki M, Yki-Jarvinen H, Voipio-Pulkki LM, Harkonen R, Haaparanta M, and Nuutila P: The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol 27: 1359-1367, 1995.
59. Fery F, Plat L, Baleriaux M, and Balasse EO: Inhibition of lipolysis stimulates whole body glucose production and disposal in normal postabsorptive subjects. J Clin Endocrinol Metab 82: 825-830, 1997.
60. Piatti PM, Monti L, Davis SN, Conti M, Brown MD, Pozza G, and Alberti KG: Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients. Diabetologia 39: 103-112, 1996.
61. Fulcher GR, Walker M, Farrer M, Johnson AS, and Alberti KGMM: Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate. Metabolism 42: 308-314, 1993.
62. Christie AW, McCormick DK, Emmison N, Kraemer FB, Alberti KG, and Yeaman SJ: Mechanism of anti-lipolytic action of acipimox in isolated rat adipocytes. Diabetologia 39: 45-53, 1996.
63. Boden G, Chen X, Rosner J, and Barton M: Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44: 1239-1242, 1995.
64. Boden G, and Chen X: Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 96: 1261-1268, 1995.
65. Bevilacqua S, Bonadonna R, Buzzigoli G, Boni C, Ciociaro D, Maccari F, Giorico MA, and Ferrannini E: Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metabolism 36: 502-506, 1987.
66. Clore JN, Glickman PS, Nestler JE, and Blackard WG: In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans. Am J Physiol 261: E425-E429, 1991.
67. Lewis GF, Zinman B, Groenewoud Y, Vranic M, and Giacca A: Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 45: 454-462, 1996.
68. Lewis GF, Vranic M, Harley P, and Giacca A: Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes 46: 1111-1119, 1997.
69. Kelley DE, Reilly JP, Veneman T, and Mandarine LJ: Effects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans. Am J Physiol 258: E923-E929, 1990.
70. Saloranta C, Koivisto V, Widen E, Falholt K, De Fronzo RA, Harkonen M, and Groop L: Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am J Physiol 264: E599-E605, 1993.
71. Laville M, Rigalleau V, Riou JP, and Beylot M: Respective role of plasma nonesterified fatty acid oxidation and total lipid oxidation in lipid induced insulin resistance. Metabolism 44: 639-644, 1995.
72. Groop LC, Bonadonna RC, Shank M, Petrides AS, and DeFronzo RA: Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J Clin Invest 87: 83-89, 1991.
73. Fanelli CG, Defeo P, Porcellati F, Perriello G, Torlone E, Santeusanio F, Brunetti P, and Bolli GB: Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counter-regulation in humans by stimulating lipolysis. J Clin Invest 89: 2005-2013, 1992.
74. Capaldo B, Napoli R, Di Bonito P, Albano G, and Sacca L: Dual mechanism of insulin action on human skeletal muscle: identification of indirect component not mediated by FFA. Am J Physiol 260: E389-E394, 1991.
75. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, and DeFronzo R: The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and non insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 72: 96-106, 1991.
76. Hargreaves M, Kiens B, and Richter A: Effect of increased plasma free fatty acid concentrations on muscle metabolism in exercising men. J Appl Physiol 70: 194-201, 1991.
77. Ravussin E, Bogardus C, Scheidegger K, LaG-range B, Horton ED, and Horton ES: Effect of elevated FFA on carbohydrate and lipid oxidation during prolonged exercise in humans. J Appl Physiol 60: 893-900, 1986.
78. Balasse EO, and Neef MA: Influence of nicotinic acid on the rates of turnover and oxidation of plasma glucose in man. Metabolism 22, 1193-1204, 1973.
79. Rigalleau V, Guillot C, De-Tinguy E, Iron A, Deleris G, and Gin H: Effect of lipid infusion on postabsorptive glucose metabolism in non-insulin-dependent diabetic patients. Metabolism 43: 1300-1304, 1994.
80. Arslanian S, and Suprasongsin C: Glucose fatty acid interactions in prepubertal and pubertal children: effects of lipid infusion. Am J Physiol 272: E523-E529, 1997.
81. Seyffert WA Jr, and Madison LL: Physiologic effects of metabolic fuels on carbohydrate metabolism. 1. Acute effect of elevation of plasma free fatty acids on hepatic glucose output, peripheral glucose utilization, serum insulin and plasma glucagon levels. Diabetes 16: 765-776, 1967.
82. Kotze JP, and Steinberg D: The effects of free fatty acid infusion on glucose metabolism in normal and streptozotocin-treated dogs. S Afr Med J 49: 1655-1660.
83. Shaw JHF, and Wolfe RR: Influence of B-hydroxybutyrate infusion on glucose and free fatty acid metabolism in dogs. Am J Physiol 247: 756-764, 1984.
84. Sindelar DK, Chu CA, Roblie M, Neal DW, Swift LL, and Cherrington AD: The role of fatty acids in modulating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 46: 187-196, 1997.
85. Hendrick GK, Frizzell RT, and Cherrington AD: Effect of somatostatin on nonesterified fatty acid levels modifies glucose homeostasis during fasting. Am J Physiol 253: E443-E452, 1987.
86. Wasserman DH, Lickley HLA, and Vranic M: Role of beta-adrenergic mechanisms during exercise in poorly controlled insulin-deficient animals. J Appl Physiol 59: 1282-1289, 1985.
87. Yamatani K, Shi ZQ, Glacca A, Gupta SF, Lickley LA, and Vranic M: Role of FFA-glucose cycle in glucoregulation during exercise in total absence of insulin. Am J Physiol 263: E646-E653, 1992.
88. Shi ZQ, Glacca A, Yamatani K, Fisher SJ, Lickley LA, and Vranic M: Effects of subbasal insulin infusion on resting and exercise-induced glucose turnover in depancreatized dogs. Am J Physiol, 264: E334-E341, 1993.
89. Fisher SJ, Lekas M, Shi ZQ, Bilinski D, Carvallio G, Glacca A, and Vranic M: Insulin-independent acute restoration of euglycaemia normalizes the impaired glucose clearance during exercise in diabetic dogs. Diabetes 46: 1805-1812, 1997.
90. Bjorkman O, Miles P, Wasserman D, Lickley L, and Vranic M: Regulation of glucose turnover during exercise in pancreatectomized totally insulin deficient dogs: effect of beta adrenergic blockade. J Clin Invest 81: 1759-1767, 1988.
91. Rebrin K, Steil GM, Getty L, and Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44: 1038-1045.
92. Bryson JM, Cooney GJ, Wensley VR, Phuyal JL, and Caterson ID: The effects of the inhibition of fatty acid oxidation on pyruvate dehydrogenase complex activity in tissues of lean and obese mice. Int J Obes Relat Metab Disord 20: 738-744, 1996.
93. Lee SM, Bahl JJ, and Bressler R: Prevention of the metabolic effects of 2-tetradecylglycidate by octanoic acid in the genetically diabetic mouse (db/db). Biochem Med 33: 104-109, 1983.
94. Jenkins AB, Storlein LH, Chisholm DJ, and Kraegen EW: Effects of nonesterified fatty acid availability on tissue-specific glucose utilization in rats in vivo. J Clin Invest 82: 293-299, 1988.
95. 31P NMR studies on the effects of increased plasma free fatty acids on intramuscular glucose medtabolism in the awake rat. J Biol Chem 272: 10464-10473, 1997.
96. Kruszynska YT, McCormack JG, and McIntyre N: Effects of non-esterified fatty acid availability on insulin stimulated glucose utiliszation and tissue pyruvate dehydrogenase activity in the rat. Diabetologia 33: 396-402, 1990.
97. Kruszynska YT, McCormack JG, and McIntyre N: Effects of glycogen stores and non-esterified fatty acid availability on insulin stimulated glucose metabolism and tissue pyruvate dehydrogenase activity in the rat. Diabetologia 34: 205-211, 1991.
98. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, and Kraegen EW: Influence of dietary fat composition on development of insulin resistance in rats; relationship to muscle triglyceride and ω-3 fatty acids in muscle phospholipid. Diabetes 40: 280-289, 1991.
99. Eckel J, Asskamp B, and Reinauer H: Induction of insulin resistance in primary cultured adult cardiac myocytes. Endocrinology 129: 345-352, 1991.
100. Svedberg J, Bjorntorp P, Smith U, and Lonroth P: Free fatty acid inhibition of insulin binding, degradation and action in isolated rat hepatocytes. Diabetes 39: 570-574, 1990.
101. Svedberg J, Bjorntorp P, Lonroth P, and Smith U: Prevention of inhibitory effect of free fatty acids on insulin binding and action in isolated rat hepatocytes by etomoxir. Diabetes 40: 783-786, 1991.
102. Svedberg J, Stromblad, G, Wirth A, Smith U, and Bjorntorp P: Fatty acids in the portal vein of the rat regulate hepatic insulin clearance. J Clin Invest 88: 2054-2058, 1991.
103. Van-Epps-Fung M, Williford J, Wells A, and Hardy RW: Fatty acid-induced insulin resistance in adipocytes. Endocrinology 138: 4338-4445.
104. Venkatesan N, Davidson MB, and Hutchinson A: Possible role for the glucose-fatty acid cycle in dexamethasone-induced insulin antagonism in rats. Metabolism 36: 883-891, 1987.
105. Venkatesan N, Lim J, Bouch C, Marciano D, and Davidson MB: Dexamethasone induced impairment in skeletal muscle glucose transport is not reversed by inhibition of free fatty acid oxidation. Metabolism 45: 92-100, 1996.
106. Guillaume-Gentil C, Assimacopoulos Jeannet F, and Jeanrenaud B: Involvement of nonesterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats. Diabetologia 36: 899-906, 1993.
107. Gonzalez-Manchon C, Martin-Requero A, Ayuso MS, and Parrilla R: Role of endogenous fatty acids in the control of hepatic gluconeogenesis. Arch Biochem Biophys 292: 95-101, 1992.
108. Martin C, Odeon M, Cohen R, and Beylot, M: Mechanisms of the glucose lowering effect of a carnitine palmitoyl transferase inhibitor in normal and diabetic rats. Metabolism 40: 420-427, 1991.
109. Storlien LH, Oakes ND, Pan DA, Kusunoki M, and Jenkins AB: Syndromes of insulin resistance in the rat: inducement by diet and amelioration with benfluorex. Diabetes 42: 457-462, 1993.
110. Jordan HN, and Phillips RW: Effect of fatty acids on isolated ovine pancreatic islets. Am J Physiol 234: E162-E167, 1978.
111. Campillo JE, Valdivia MM, Rodriguez E, and Osorio C: Effect of oleic and octanoic acids on glucose induced insulin release in vitro. Diabete Metab 5: 183-187, 1979.
112. Sako Y, and Grill VE: A 48 hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 127: 1580-1589, 1990.
113. Zhou YP, and Grill VE: Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93: 870-876, 1994.
114. Zhou YP, and Grill VE: Palmitate-induced beta-cell insensitivity to glucose is coupled to decreased pyruvate dehydrogenase activity and enhanced kinase activity in rat pancreatic islets. Diabetes 44: 394-399, 1995.
115. Zhou YP, and Grill V: Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. J Clin Endocrinol Metab 80: 1584-1590, 1995.
116. Zhou YP, Priestman DA, Randle PJ, and Grill VE: Fasting and decreased B cell sensitivity: important role for fatty acid-induced inhibition of PDH activity. Am J Physiol 270: E988-E994, 1996.
117. Zhou YP, Ling ZC, and Grill VE: Inhibitory effects of fatty acids on glucose-regulated B-cell function: association with increased islet triglyceride stores and altered effect of fatty acid oxidation on glucose metabolism. Metabolism 45: 981-986, 1996.
118. Zhou YP, Berggren PO, and Grill VE: A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta cell dysfunction in the obese diabetic db/db mouse. Diabetes 45: 580-586, 1996.
119. Ashcroft SJH: Glucoreceptor mechanisms and the control of insulin release and biosynthesis. Diabetologia 18: 5-15, 1980.
120. Meglasson MD, and Matschinsky FM: Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes/Metab Rev 2: 163-214, 1986.
121. Ashcroft FM, Proks P, Smith PA, Ämmälä C, Bokvist K, and Rorsman P: Stimulus-secretion coupling in pancreatic P cells. J Cell Biochem 55S: 54-65.
122. 2+ as a second messenger within mitochondria of the heart and other tissues. Annu Rev Physiol 52: 451-466, 1990.
123. McCormack JG, Longo EA, and Corkey BE: Glucose-induced activation of pyruvate dehydrogenase in isolated rat pancreatic islets. Biochem J 257: 527-530, 1990.
124. Liang Y, Buettger C, Berner DK, and Matschinsky FM: Chronic effect of fatty acids on insulin release is not through the alteration of glucose metabolism in a pancreatic beta cell line. Diabetologia 40: 1018-1027, 1997.
125. Warnotte C, Gilon P, Nenquin M, and Henquin JC: Mechanisms of the stimulation of insulin release by saturated fatty acids: a study of palmitate effects in mouse beta-cells. Diabetes 43: 703-711, 1994.
126. Elks ML: Divergent effects of arachidonate and other free fatty acids on glucose-stimulated insulin release from rat islets. Cell Mol Biol 40: 761-768, 1994.
127. 2+ mobilization and protein kinase C. Diabetes 37: 1453-1469, 1988.
128. Stein DT, Esser V, Stevenson BE, Lane KE, Whiteside JH, Daniels MB, Chen S, and McGarry JD: Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97: 2728-2735, 1996.
129. Stein DT, Stevenson BE, Chester MW, Basit M, Daniels MB, Turley SD, and McGarry JD: The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 100: 398-403, 1997.
130. Assimacopoulos-Jeannet F, Thumelin S, Roche E, Esser V, McGarry JD, and Prentki M: Fatty acids rapidly induce the carnitine palmitoyl-transferase I gene in the pancreatic beta-cell line INS-1. J Biol Chem 272: 1659-1664, 1997.
131. Chen SY, Ogawa A, Ohneda M, Unger RH, Foster DW, and McGarry JD: More direct evidence for a malonyl-CoA-carnitine palmitoyl-transferase I interaction as a key event in pancreatic beta-cell signaling. Diabetes 43: 878-883, 1994.
132. Brun T, Roche E, Assimacopoulos-Jeannet F, Corkey BE, Kim KH, and Prentki M: Evidence for an anaplerotic/malonyl-CoA pathway in pancreatic beta-cell nutrient signaling. Diabetes 45: 190-198, 1996.
133. Zhang S, and Kim KH: Glucose activation of acetyl-CoA carboxylase in association with insulin secretion in a pancreatic beta-cell line. J Endocrinol 147: 33-41, 1995.
134. Brun T, Assimacopoulos-Jeannet F, Corkey BE, and Prentki M: Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1. Diabetes 46: 393-400, 1997.
135. Fulceri R, Nori A, Gamberucci A, Volpe P, Giunti R, and Benedetti, A. Fatty acylCoA esters induce calcium release from terminal cisternae of skeletal muscle. Cell Calcium 15: 109-116, 1994.
136. Branstrom R, Corkey BE, Berggren PO, Larsson OE: Evidence for a unique long chain acyl-CoA ester binding site on the ATP-regulated potassium channel in mouse pancreatic beta cells. J Biol Chem 272: 17390-17394, 1997.
137. + channel by long chain acyl-CoA: a role in modulation of pancreatic beta-cell glucose sensitivity. J Biol Chem 271: 10623-10626, 1996.
138. Randle PJ: Fuel selection in animals. Nineteenth Ciba Medal Lecture. Biochem Soc Trans 14: 799-806, 1986.
139. Randle PJ, Priestman DA, Mistry SC, and Halsail A: Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia 37 (Suppl. 2): S155-S161, 1995.
140. Harris RA, and Popov KM: The mitochondrial α-ketoacid dehydrogenase kinases: molecular cloning, tissue-specific expression and primary structure analysis. In Alpha-Keto Acid Dehydrogenase Complexes, Patel MS, Roche TE, and Harris RA, Eds. Birkhauser, Basel, 1996, pp. 139-149.
141. Harris RA, Hawes JW, Popov KM, Zhao Y, Shimomura Y, Sato J, Jaskiewicz J, and Hurley TD: Studies on the regulation of the mitochondrial alpha-ketoacid dehydrogenase complexes and their kinases. Adv Enzyme Regul 37: 271-293, 1997.
142. Bowker-Kinley MM, Davis WI, Wu P, Harris RA, and Popov KM: Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem J 329: 191-196, 1998.
143. Roche TE, Lau S, Ravindran S, Baker JC, and Wang L: Role of the E2 core in the dominant mechanism of regulatory control of mammalian pyruvate dehydrogenase complex. In Alpha-Keto Acid Dehydrogenase Complexes, Patel MS, Roche TE, and Harris RA, Eds. Birkhäuser, Basel, 1996, pp. 33-52.
144. Hutson NJ, and Randle PJ: Enhanced activity of pyruvate dehydrogenase kinase in rat heart mitochondria in alloxan-diabetes or starvation. FEBS Letts 92: 73-76, 1978.
145. Fuller SJ, and Randle PJ: Reversible phosphorylation of pyruvate dehydrogenase in rat skeletal-muscle mitochondria. Biochem J 219: 635-646, 1984.
146. Denyer GS, Kerbey AL, and Randle PJ: Kinase activator protein mediates longer-term effects of starvation on activity of pyruvate dehydrogenase kinase in rat liver mitochondria. Biochem J 239: 347-354, 1986.
147. Marchington DR, Kerbey AL, Giardina MG, Jones EA, and Randle PJ: Longer term regulation of pyruvate dehydrogenase kinase in cultured rat hepatocytes. Biochem J 257: 487-491, 1989.
148. Marchington DR, Kerbey AL, and Randle PJ: Longer term regulation of pyruvate dehydrogenase in cultured rat cardiac myocytes. Biochem J 267: 245-247, 1990.
149. Stace PB, Fatania HR, Jackson A, Kerbey AL, and Randle PJ: Cyclic AMP and free fatty acids in the longer-term regulation of pyruvate dehydrogenase kinase in rat soleus muscle. Biochim Biophys Acta 1135: 201-206, 1992.
150. Kerbey AL, and Randle PJ: Thermolabile factor accelerates pyruvate dehydrogenase kinase reaction in heart mitochondria of starved or alloxan diabetic rats. FEBS Lett 127: 188-192, 1981.
151. Kerbey AL, and Randle PJ: Pyruvate dehydrogenase kinase/activator in rat heart mitochondria. Biochem J 206: 103-111, 1982.
152. Mistry SC, Priestman DA, Kerbey AL, and Randle PJ: Evidence that rat liver pyruvate dehydrogenase kinase activator protein is a pyruvate dehydrogenase kinase. Biochem J 275: 775-779, 1991.
153. Priestman DA, Mistry SC, Halsall A, and Randle PJ: Role of protein synthesis and of fatty acid metabolism in the longer term regulation of pyruvate dehydrogenase kinase. Biochem J 300: 659-664, 1994.
154. Caterson ID, Fuller SJ, and Randle PJ: Effect of the fatty acid oxidation inhibitor 2-tetradecyl-glycidic acid on pyruvate dehydrogenase complex activity in starved and diabetic rats. Biochem J 208: 53-60, 1982.
155. Sugden MC, Fryer LG, Orfali KA, Priestman DA, Donald E, and Holness MJ: Studies of the long-term regulation of hepatic pyruvate dehydrogenase kinase. Biochem J 329: 89-94, 1998.
156. Fryer LG, Orfali KA, Holness MJ, Saggerson ED, and Sugden MC: The long-term regulation of skeletal muscle pyruvate dehydrogenase kinase by dietary lipid is dependent on fatty acid composition. Eur J Biochem 229; 741-748, 1995.
157. Sugden MC, Orfali KA, Fryer LGD, Holness MJ, and Priestman DA: Molecular mechanisms underlying the long-term impact of dietary fat to increase cardiac pyruvate dehydrogenase kinase: regulation by insulin, cyclic AMP and pyruvate. J Mol Cell Cardiol 29: 1867-1875, 1997.
158. Hue L, Maisin L, and Rider MH: Palmitate inhibits liver glycolysis: involvement of fructose 2,6 bisphosphate in the glucose/fatty acid cycle. Biochem J 251: 541-545, 1988.
159. Claus TH, El Maghrabi MR, Regen DM, Stewart H, McGrane M, Kountz PD, Nyfeler F, Pilkis J, and Pilkis SJ: The role of fructose 2,6-bisphosphate in the regulation of carbohydrate metabolism. Curr Top Cell Regul 23: 57-86, 1984.
160. Gautier JF, and Cathelineau G. Insulin sensitivity and hepatic glucose production: nycthemeral variations. Diabetes Metab 23 (Suppl. 4): 35-38, 1997.
161. Mittelman SD, Fu YY, Rebrin K, Steil G, and Bergman RN: Indirect effect of insulin to suppress endogenous glucose production is dominant even with hyperglucagonaemia. J Clin Invest 100: 3121-3130, 1997.
162. Sindelar DK, Chu CA, Rohlie M, Neal DW, Swift LL, and Cherrington AD: The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 46: 187-196, 1997.
163. Perriello G, Misericordia P, Volpi E, Santucci A, Santucci C, Ferannini E, Ventura MM, Santeusabio F, Brunett P, and Bolli GB: Acute antihyperglycaemic mechanisms of metformin: evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes 43: 920-928, 1994.
164. Puhakainen I, and Yki-Jarvinen H: Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycaemia or total hepatic glucose production in MIDDM. Diabetes 42: 1694-1699, 1993.
165. Ratheiser K, Schneeweiss B, Waldhausl W, Fasching P, Korn A, Nowotny P, Rohac M, and Wolf HP: Inhibition by etomoxir of carnitine palmitoyltransferase I reduces hepatic glucose production and plasma lipids in non-insulin dependent diabetes mellitus. Metabolism 40: 1185-1190, 1991.
166. Saloranta C, Franssila-Kallunki A, Ekstrand A, Taskinen MR, and Groop L: Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34: 409-415, 1991.
167. Wolfe RR, and Shaw JH: Inhibitory effect of plasma free fatty acids on glucose production in the conscious dog. Am J Physiol 246: E181-E186, 1984.
168. Shaw JH, and Wolfe RR: Glucose production in the perfused dog liver: effect of free fatty acids and ketones. J Surg Res 37: 437-442, 1984.
169. Fery F, Plat L, Baleriaux M, and Balasse EO: Inhibition of lipolysis stimulates whole body glucose production and disposal in normal postabsorptive subjects. J Clin Endocrinol Metab 82: 825-830, 1997.
170. Hargrieves M, Kiens B, and Richter EA: Effect of increased plasma free fatty acid concentrations on muscle metabolism in exercising men. J Appl Physiol 70: 194-201, 1991.
171. Henriksen EJ, Jacob S, Fogt DL, Youngblood EB, and Godicke J: Antihypertensive agent moxonidine enhances muscle glucose transport in insulin-resistant rats. Hypertension 30: 1560-1565, 1997.
172. Kim JK, Wi JK, and Youn JH: Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats. Diabetes 45: 446-453, 1996.
173. Galuska D, Nolte L, Wahlstrom E, Smedegaard-Kristensen JS, Wallberg-Henriksson H, and Zierath JR: Effects of non-esterified fatty acids on insulin-stimulated glucose transport in isolated skeletal muscle from patients with type 2 (non-insulin-dependent) diabetes mellitus. Acta Diabetol 31: 169-172, 1994.
174. Nolte LA, Galuska D, Martin IK, Zierath JR, and Wallberg-Henriksson H: Elevated free fatty acid levels inhibit glucose phosphorylation in slow-twitch rat skeletal muscle: elevated free fatty acid levels inhibit glucose phosphorylation in slow-twitch rat skeletal muscle. Acta Physiol Scand 151: 51-59, 1994.